An observational study to examine whether the diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy.
Phase of Trial: Phase IV
Latest Information Update: 24 Dec 2015
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions
- 24 Dec 2015 New trial record